News

Xalkori blocks signaling in a number of cell pathways supposed to be important for the growth and survival of tumor cells, by inhibiting the ALK fusion protein. With

Using Pincer platform, Mediomics will develop antigen-specific assays for antibody titer, affinity, glycosylation and aggregation and is also expected to culminate with beta-testing by Gallus Biopharmaceuticals. The company

According to the study data, the oral administration of laquinimod 0.5mg/day exhibitted the steady effect on remission and response rates in patients with moderate-to-severe CD versus placebo. Teva

The international study, which involved 775 patients with UC and 525 HCPs, in UC compared the views and beliefs of patients, physicians and specialist nurses. The survey, which

RPC1063 is a S1P1 selective modulator, which shows picomolar potency that is effective in rodent models of both multiple sclerosis and inflammatory bowel disease and has safety profile

For the completion, the company has initiated the installation qualification (IQ) validation process through Biopharmax Group, which is handling the build-out of Pluristem’s facility. Following the successful IQ,

The new solution, BINOSTO (alendronate sodium), is intended for the treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. EffRx Pharmaceuticals chairman

The NDA included the data of clinical studies in more than 3,000 pregnant women at term including the EXPEDITE study. The 1,358 patient-based double blind, randomized, multicenter EXPEDITE

Tamoxifen Citrate is the most common drug prescribed to treat breast cancer. Soltamox is expected to offer treatment option for patients who need tamoxifen and also solve difficulties of